Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease

18Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting 5%of the elderly population. Currently, the diagnosis of PD is mainly based on clinical features and no definitive diagnostic biomarkers have been identified. The discovery of biomarkers at the earliest stages of PD is of extreme interest. This review focuses on the current findings in the field of circulating non-coding RNAs in PD. We briefly describe the more established circulating biomarkers in PD and provide a more thorough review of non-coding RNAs, in particular microRNAs, long non-coding RNAs and circular RNAs, differentially expressed in PD, highlighting their potential for being considered as biomarkers for diagnosis. Together, these studies hold promise for the use of peripheral biomarkers for the diagnosis of PD.

Cite

CITATION STYLE

APA

Manna, I., Quattrone, A., De Benedittis, S., Iaccino, E., & Quattrone, A. (2021). Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson’s Disease. Journal of Parkinson’s Disease. IOS Press BV. https://doi.org/10.3233/jpd-212726

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free